BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 26883728)

  • 1. Fc receptor-mediated phagocytosis in tissues as a potent mechanism for preventive and therapeutic HIV vaccine strategies.
    Sips M; Krykbaeva M; Diefenbach TJ; Ghebremichael M; Bowman BA; Dugast AS; Boesch AW; Streeck H; Kwon DS; Ackerman ME; Suscovich TJ; Brouckaert P; Schacker TW; Alter G
    Mucosal Immunol; 2016 Nov; 9(6):1584-1595. PubMed ID: 26883728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Broadly Neutralizing Antibodies Display Potential for Prevention of HIV-1 Infection of Mucosal Tissue Superior to That of Nonneutralizing Antibodies.
    Cheeseman HM; Olejniczak NJ; Rogers PM; Evans AB; King DFL; Ziprin P; Liao HX; Haynes BF; Shattock RJ
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of Antibody-Dependent Cellular Cytotoxicity and Phagocytosis in Anti-HIV-1 Human-Bovine Chimeric Broadly Neutralizing Antibodies.
    Edwards JM; Heydarchi B; Khoury G; Salazar-Quiroz NA; Gonelli CA; Wines B; Hogarth PM; Kristensen AB; Parsons MS; Purcell DFJ
    J Virol; 2021 Jun; 95(13):e0021921. PubMed ID: 33853957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophils mediate HIV-specific antibody-dependent phagocytosis and ADCC.
    Worley MJ; Fei K; Lopez-Denman AJ; Kelleher AD; Kent SJ; Chung AW
    J Immunol Methods; 2018 Jun; 457():41-52. PubMed ID: 29605231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical Tenofovir Pre-exposure Prophylaxis and Mucosal HIV-Specific Fc-Mediated Antibody Activities in Women.
    Fisher KL; Mabuka JM; Sivro A; Ngcapu S; Passmore JS; Osman F; Ndlovu B; Abdool Karim Q; Abdool Karim SS; Chung AW; Baxter C; Archary D
    Front Immunol; 2020; 11():1274. PubMed ID: 32733445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody Functional Assays as Measures of Fc Receptor-Mediated Immunity to HIV - New Technologies and their Impact on the HIV Vaccine Field.
    Wines BD; Billings H; Mclean MR; Kent SJ; Hogarth PM
    Curr HIV Res; 2017; 15(3):202-215. PubMed ID: 28322167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant gp120 vaccine-induced antibodies inhibit clinical strains of HIV-1 in the presence of Fc receptor-bearing effector cells and correlate inversely with HIV infection rate.
    Forthal DN; Gilbert PB; Landucci G; Phan T
    J Immunol; 2007 May; 178(10):6596-603. PubMed ID: 17475891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1-Specific IgA Monoclonal Antibodies from an HIV-1 Vaccinee Mediate Galactosylceramide Blocking and Phagocytosis.
    Wills S; Hwang KK; Liu P; Dennison SM; Tay MZ; Shen X; Pollara J; Lucas JT; Parks R; Rerks-Ngarm S; Pitisuttithum P; Nitayapan S; Kaewkungwal J; Thomas R; Kim JH; Michael NL; Robb ML; McRaven M; Montefiori DC; Hope TJ; Liao HX; Moody MA; Ferrari G; Haynes BF; Alam SM; Bonsignori M; Tomaras GD
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29321320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression Profile of Human Fc Receptors in Mucosal Tissue: Implications for Antibody-Dependent Cellular Effector Functions Targeting HIV-1 Transmission.
    Cheeseman HM; Carias AM; Evans AB; Olejniczak NJ; Ziprin P; King DF; Hope TJ; Shattock RJ
    PLoS One; 2016; 11(5):e0154656. PubMed ID: 27164006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct Immunoglobulin Fc Glycosylation Patterns Are Associated with Disease Nonprogression and Broadly Neutralizing Antibody Responses in Children with HIV Infection.
    Muenchhoff M; Chung AW; Roider J; Dugast AS; Richardson S; Kløverpris H; Leslie A; Ndung'u T; Moore P; Alter G; Goulder PJR
    mSphere; 2020 Dec; 5(6):. PubMed ID: 33361123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral control in chronic HIV-1 subtype C infection is associated with enrichment of p24 IgG1 with Fc effector activity.
    Chung AW; Mabuka JM; Ndlovu B; Licht A; Robinson H; Ramlakhan Y; Ghebremichael M; Reddy T; Goulder PJR; Walker BD; Ndung'u T; Alter G
    AIDS; 2018 Jun; 32(10):1207-1217. PubMed ID: 29620716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccine-Induced Antibodies Mediate Higher Antibody-Dependent Cellular Cytotoxicity After Interleukin-15 Pretreatment of Natural Killer Effector Cells.
    Fisher L; Zinter M; Stanfield-Oakley S; Carpp LN; Edwards RW; Denny T; Moodie Z; Laher F; Bekker LG; McElrath MJ; Gilbert PB; Corey L; Tomaras G; Pollara J; Ferrari G
    Front Immunol; 2019; 10():2741. PubMed ID: 31827470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonneutralizing functional antibodies: a new "old" paradigm for HIV vaccines.
    Excler JL; Ake J; Robb ML; Kim JH; Plotkin SA
    Clin Vaccine Immunol; 2014 Aug; 21(8):1023-36. PubMed ID: 24920599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary Human Neutrophils Exhibit a Unique HIV-Directed Antibody-Dependent Phagocytosis Profile.
    Powell RLR; Fox A; Itri V; Zolla-Pazner S
    J Innate Immun; 2019; 11(2):181-190. PubMed ID: 30557875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bridging Vaccine-Induced HIV-1 Neutralizing and Effector Antibody Responses in Rabbit and Rhesus Macaque Animal Models.
    Pollara J; Jones DI; Huffman T; Edwards RW; Dennis M; Li SH; Jha S; Goodman D; Kumar A; LaBranche CC; Montefiori DC; Fouda GG; Hope TJ; Tomaras GD; Staats HF; Ferrari G; Permar SR
    J Virol; 2019 May; 93(10):. PubMed ID: 30842326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody-Mediated Internalization of Infectious HIV-1 Virions Differs among Antibody Isotypes and Subclasses.
    Tay MZ; Liu P; Williams LD; McRaven MD; Sawant S; Gurley TC; Xu TT; Dennison SM; Liao HX; Chenine AL; Alam SM; Moody MA; Hope TJ; Haynes BF; Tomaras GD
    PLoS Pathog; 2016 Aug; 12(8):e1005817. PubMed ID: 27579713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-specific antibody immunity mediated through NK cells and monocytes.
    Kramski M; Parsons MS; Stratov I; Kent SJ
    Curr HIV Res; 2013 Jul; 11(5):388-406. PubMed ID: 24191935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural definition of an antibody-dependent cellular cytotoxicity response implicated in reduced risk for HIV-1 infection.
    Acharya P; Tolbert WD; Gohain N; Wu X; Yu L; Liu T; Huang W; Huang CC; Kwon YD; Louder RK; Luongo TS; McLellan JS; Pancera M; Yang Y; Zhang B; Flinko R; Foulke JS; Sajadi MM; Kamin-Lewis R; Robinson JE; Martin L; Kwong PD; Guan Y; DeVico AL; Lewis GK; Pazgier M
    J Virol; 2014 Nov; 88(21):12895-906. PubMed ID: 25165110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on Fc-Mediated Antibody Functions Against HIV-1 Beyond Neutralization.
    Su B; Dispinseri S; Iannone V; Zhang T; Wu H; Carapito R; Bahram S; Scarlatti G; Moog C
    Front Immunol; 2019; 10():2968. PubMed ID: 31921207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Broadly Neutralizing Hemagglutinin Stalk-Specific Antibodies Induce Potent Phagocytosis of Immune Complexes by Neutrophils in an Fc-Dependent Manner.
    Mullarkey CE; Bailey MJ; Golubeva DA; Tan GS; Nachbagauer R; He W; Novakowski KE; Bowdish DM; Miller MS; Palese P
    mBio; 2016 Oct; 7(5):. PubMed ID: 27703076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.